Cerus (CERS) Debt Ratio (2010 - 2026)

Cerus (CERS) reported Debt Ratio of 0.38 for Q1 2026, down 7.39% on a YoY basis from 0.41 in Q1 2025, and up 0.65% sequentially from 0.38 in Q4 2025.

Cerus (CERS) Debt Ratio (2010 - 2026) Analysis & Trends

Cerus (CERS) has 17 years of Debt Ratio data on file, last reported at 0.38 in Q1 2026.

For the quarter ending Q1 2026, Debt Ratio fell 7.39% year-over-year to 0.38; the trailing twelve-month figure through Mar 2026 stood at 0.38 (down 7.39% YoY), and the FY2025 full-year result was 0.38, down 9.73% from the prior year.
Debt Ratio advanced to 0.38 in Q1 2026, from 0.38 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.45 in Q2 2024 to a low of 0.31 in Q1 2022.
A 5-year average of 0.38 and a median of 0.38 in 2023 frame the typical range for Debt Ratio.
Across the five-year window, Debt Ratio increased 29.1% in 2024 and retreated 11.62% in 2025, its largest moves.
Tracing CERS's Debt Ratio over 5 years: stood at 0.32 in 2022, then climbed by 26.08% to 0.4 in 2023, then grew by 3.8% to 0.42 in 2024, then retreated by 9.73% to 0.38 in 2025, then grew by 0.65% to 0.38 in 2026.
Business Quant data shows CERS's Debt Ratio at 0.38 in Q1 2026, 0.38 in Q4 2025, and 0.39 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	0.31
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	0.32
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	0.30
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	0.04
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	-
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	0.27
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	0.30
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	0.30
10	Cerus	600.87 Mn	520.44 Mn	27.89 Mn	0.38

Download Data